Garo H. Armen, Ph.D.

Garo H. Armen, Ph.D.

Chief Executive OfficeratAgenus· In proxies 2022–2025

Pay in FY2025-64% from the year before · Agenus stock +14.6% the same year

Garo H. Armen, Ph.D. was paid $1.4M in FY2025 (Dec), down 64%. Agenus stock rose 14.6% that year.

Pay$100 in the stock at the end of FY21 → $5
Pay is from the Summary Compensation Table of each Agenus proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. AgenusPublic company · 4 yr
    • Chief Executive Officer2022 – Present · 4 yrStock in role -90%
  2. MiNK Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. Protagenic Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Elan Corporation, plcPublic company
    • Director? – 2004No stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • AgenusChair · 26 yr on the boardNot independentExecutive—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?